アジェンダ
8:30 AM — 8:45 AM
8:45 AM — 9:30 AM
Session 1: DRUG DEVELOPMENT9:30 AM — 10:15 AM
Session 2: QUALITY FRAMEWORK10:15 AM — 10:45 AM
10:45 AM — 11:45 AM
Session 3: REGULATORY OVERVIEW10:45 AM — 11:15 AM
Session 7 continued: RESOURCING11:15 AM — 12:45 PM
Session 8: STUDY PREPARATION11:45 AM — 12:30 PM
Session 4: CLINICAL DEVELOPMENT12:30 PM — 1:30 PM
1:30 PM — 2:30 PM
Session 5: STUDY DESIGN2:00 PM — 3:30 PM
Session 6: STUDY PLANNING3:30 PM — 4:00 PM
5:30 PM — 6:30 PM
8:30 AM — 10:45 AM
Session 7: RESOURCING10:45 AM — 11:15 AM
12:45 PM — 1:45 PM
1:45 PM — 2:45 PM
Session 9: IMP MANAGEMENT2:45 PM — 4:15 PM
Session 10: STUDY COMMUNICATION3:45 PM — 4:15 PM
4:15 PM — 5:00 PM
Session 10 continued: STUDY COMMUNICATION8:30 AM — 10:15 AM
Session 11: SITE MANAGEMENT10:15 AM — 10:45 AM
10:45 AM — 11:45 AM
Session 12: EVALUATION AND REPORTING11:45 AM — 12:30 PM
Session 13: DRUG SAFETY12:30 PM — 1:30 PM
1:30 PM — 2:30 PM
Session 14: RISK MANAGEMENT2:30 PM — 3:30 PM